Keyphrases
Multiple Sclerosis
100%
Chitinase 3-like 1
100%
Cerebrospinal Fluid
100%
Newly Diagnosed Patients
100%
Neurofilament Light (NF-L)
100%
Prognostic Value
100%
Cerebrospinal Fluid Concentration
77%
Clinically Isolated Syndrome
44%
Relapse Risk
33%
Newly Diagnosed
22%
Multiple Sclerosis Treatment
22%
Univariate Analysis
11%
Disease-modifying Therapy
11%
Progressive MS
11%
Expanded Disability Status Scale
11%
Confounding
11%
Disability
11%
Disease Progression
11%
Multivariable
11%
Clinical Worsening
11%
Progressive Development
11%
Medicine and Dentistry
Multiple Sclerosis
100%
Neurofilament
100%
Light Chain
100%
Cerebrospinal Fluid
100%
Chitinase
100%
Expanded Disability Status Scale
10%
Disease Modifying Therapy
10%
Disease Exacerbation
10%
Univariate Analysis
10%
Immunology and Microbiology
Light Chain
100%
Multiple Sclerosis
100%
Neurofilament
100%
Cerebrospinal Fluid
100%
Expanded Disability Status Scale
10%
Neuroscience
Chitinase
100%
Neurofilament Light Chain
100%
Multiple Sclerosis
100%
Clinically Isolated Syndrome
44%
Expanded Disability Status Scale
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chitinase
100%
Multiple Sclerosis
100%
Syndrome
57%
Diseases
14%
Disease Exacerbation
14%
Expanded Disability Status Scale
14%